Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-Month comparison with longitudinal 2-year follow-up of effectiveness and costs

Journal of Affective Disorders

Volumn 68, Issue 2-3, 2002, Pages 317-330

  Browne, Gina ^a,e   Steiner, Meir ^a,b   Roberts, Jacqueline ^a   Gafni, Amiram ^a,c   Byrne, Carolyn ^a   Dunn, Edward ^b,d   Bell, Barbara ^a,e,f   Mills, Michael ^a,e,f   Chalklin, Lori ^a,e,f   Wallik, David ^a,e,f   Kraemer, James ^a,e,f  

^a MCMASTER UNIVERSITY   (Canada)

^b ST JOSEPH S HOSPITAL   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e Caroline Medical Group   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Dysthymic disorder; Health service organization; Health services utilization; Interpersonal psychotherapy; Primary health care; Sertraline

Indexed keywords

SERTRALINE;

ADULT; AGED; ARTICLE; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DIARRHEA; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FOLLOW UP; HEALTH CARE COST; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; NAUSEA; OBSESSION; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SINGLE BLIND PROCEDURE; SLEEP DISORDER; SOCIAL WORK; SUICIDAL BEHAVIOR; SYMPTOM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CANADA; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER, MAJOR; DYSTHYMIC DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT CARE TEAM; PRIMARY HEALTH CARE; PSYCHOTHERAPY; SERTRALINE; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 0036286076     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(01)00343-3     Document Type: Article

References (67)

1. Psychotherapy process in the National Institute of Mental Health Treatment of Depression Collaborative Research Program
2. Practice guidelines for major depressive disorder in adults
3. Depression, disability days, and days lost from work in a prospective epidemiologic survey
4. Individual correlates of health service utilization and the cost of poor adjustment to chronic illness
5. New directions in antidepressant therapy: A review of sertraline, a unique serotonin reuptake inhibitor
6. The McMaster Family Assessment Device
7. Interpersonal psychotherapy and antidepressant medication: Evaluation of a sequential treatment strategy in women with recurrent major depression
8. Natural history and preventative treatment of recurrent mood disorders
9. Cost-effectiveness of brief psychodynamic-interpersonal therapy in high utilizers of psychiatric services
10. Standardized assessment of dysthymia: Report of a National Institute of Mental Health Conference
11. The long-term outcome of dysthymia in private practice: Clinical features, temperament, and the art of management
12. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia
13. General health, health care utilization and medical comorbidity in dysthymia
14. The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder
15. Sertraline for social phobia: A double-blind, placebo-controlled crossover study
16. The treatment of chronic depression, Part 2: A double-blind, randomized trial or Sertraline and Imipramine
17. Maintenance phase efficacy of sertraline for chronic depression: A randomized controlled trial
18. A comparison of Nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression
19. Prevalence, correlates, and course of minor depression and major depression in National Comorbidity Survey
20. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States
21. Early-virus late-onset dysthymic disorder: Comparison in out-patients with superimposed major depressive episodes
22. Double-blind comparison of sertraline, imipramine and placebo in the treatment of dysthymia: Psychosocial outcomes
23. Imipramine treatment for chronic depression
24. Preclinical pharmacology of sertraline: A potent and specific inhibitor of serotonin reuptake
25. Sertraline or imipramine for chronic depression: 7 month results
26. Gender differences in chronic major and double depression
27. Pharmacological therapy of dysthymia
28. Cost-effectiveness of treatments for major depression in primary care practice
29. Social adjustment in dysthymia, double depression and episodic major depression
30. Amisulpride versus imipramine and placebo in dysthymia and major depression
31. Can enhanced acute-phase treatment in depression improve long-term outcomes? A report of randomized trials in primary care
32. Developments in interpersonal psychotherapy
33. Psychotherapy of the post-dysthymic patient
34. Psychotherapy of dysthymia
35. Interpersonal psychotherapy for dysthymic disorders
36. Cognitive-behavioral analysis system of psychotherapy: An interactional treatment approach for dysthymic disorder
37. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression
38. Profiles of antidepressant activity with the Montgomery-Asberg Depression Rating Scale
39. A new depression scale designed to be sensitive to change
40. Efficacy of interpersonal psychotherapy for depressed adolescents
41. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care
42. Sertraline 50 mg daily: The optimal dose in the treatment of depression
43. The CES-D Scale: A self-report depression scale for research in the general population
44. Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: Clinical symptoms and functional impairments
45. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: A randomized controlled trial in patients older than 59 years
46. Acute and one-year outcome of a randomized controlled trial of brief cognitive therapy for major depressive disorder in primary care
47. Delineating psychopathologic clusters within dysthymia: A study of 512 out-patients without major depression
48. The undertreatment of dysthymia
49. Initial antidepressant choice in primary care: Effectiveness and cost of fluoxetine vs. tricyclic antidepressants
50. Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: A double-blind, comparative study
51. Prevalence of dysthymic disorder in primary care
52. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia
53. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations
54. Controlled efficacy study of fluoxetine in dysthymia
55. Treatment cost, cost offset, and cost-effectiveness of collaborative management of depression
56. Dysthymia: A randomized study of cognitive marital therapy and antidepressants
57. Conjoint interpersonal psychotherapy for depressed patients with marital disputes
58. Social adjustment by self-report in a community sample and in psychiatric outpatients
59. The role of psychotherapy in chronic depressions: A proposal
60. Interpersonal psychotherapy. Current status
61. Treatment of dysthymia and minor depression in primary care. A randomized controlled trial in older adults
62. The practice and roles of the psychotherapies: A discussion paper